Spotlight on brimonidine topical gel 0.33% for facial erythema of rosacea: safety, efficacy, and patient acceptability

BACKGROUND: Brimonidine tartrate is a highly selective alpha 2 agonist that induces direct vasoconstriction of small arteries and veins, thereby reducing vasodilation and edema. OBJECTIVE: To review the current literature regarding the safety, efficacy, and patient acceptability of brimonidine 0.33%...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Patient Prefer Adherence
Hlavní autoři: Anderson, Michael S, Nadkarni, Anish, Cardwell, Leah A, Alinia, Hossein, Feldman, Steven R
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2017
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5505675/
https://ncbi.nlm.nih.gov/pubmed/28740369
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S115708
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky